LivaNova PLC
LIVNNASDAQHealthcareMedical Devices
As of Oct 16, 2026 close
- Market cap
- $4.42B
- P/E (TTM)
- 23.43
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $48.82$85.76
- Volume (live)
- -
- Avg. volume (3M)
- 642.27K
LivaNova (LIVN) Stock Price & Financial Analysis
LivaNova Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $77.18 - $79.31 |
|---|---|
| 52-Week High | $85.76 |
| 52-Week Low | $48.82 |
| Open | $78.69 |
| Volume (last close) | 773.98K |
| Average Volume (3M) | 642.27K |
| Revenue (TTM) | 1.47B |
|---|---|
| Net Income (TTM) | 188.56M |
| Free Cash Flow (TTM) | 148.34M |
| EPS (TTM) | $3.38 |
| Profit Margin | 12.81% |
| Operating Margin | 13.47% |
| Return on Equity (ROE) | 14.23% |
| Debt to Equity | 0.27 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 4.42B |
|---|---|
| Shares Outstanding | 56.27M |
| P/E Ratio (TTM) | 23.43 |
| Price to Sales (P/S) | 3.00 |
| Price to Book (P/B) | 3.33 |
| EV/EBITDA | 18.33 |
| 50-Day MA | $78.38 |
|---|---|
| 200-Day MA | $71.88 |
| 1-Year Change | +46.10% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
LivaNova at a Glance
As of the Oct 16, 2026 close, LivaNova (LIVN) has a market capitalization of $4.42B. The stock trades at 23.4× trailing earnings and 3.0× sales. Over the trailing twelve months it earned $188.56M on revenue of $1.47B (a 12.8% profit margin) and generated $148.34M of free cash flow. Revenue grew 12.4% year over year.
As of its latest reported balance sheet, it holds $516.62M in cash and securities against $351.95M of debt, a net cash position of $164.67M.
LivaNova does not currently pay a dividend.
The share price is up 46.1% over the past year. At $77.58 (the Oct 16, 2026 close) it sits within its 52-week range of $48.82 to $85.76, above its 200-day moving average of $71.88.
Based on 7 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $89.60, 15.5% above the Oct 16, 2026 close.
Frequently Asked Questions About LivaNova
What is the current stock price for LIVN?
As of the Oct 16, 2026 close, LIVN stock trades at $77.58. The 52-week range is $48.82–$85.76, with a day range of $77.18–$79.31.
What is the P/E ratio for LIVN?
As of the Oct 16, 2026 close, LivaNova's trailing twelve-month (TTM) P/E ratio is 23.4, meaning investors pay $23.4 for every $1 of annual earnings. LivaNova operates in the Healthcare sector.
Does LIVN pay dividends?
LivaNova does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for LIVN?
Based on ratings from 7 professional analysts over the last 90 days, the consensus for LIVN is Buy. The average 12-month price target is $89.60, a 15.5% upside from the Oct 16, 2026 close of $77.58.
What is the market cap of LIVN?
As of the Oct 16, 2026 close, LivaNova's market capitalization is $4.37B, classifying it as a mid-cap company. LivaNova operates in the Healthcare sector within the Medical Devices industry.